Multiple somatic mutations at the CD have clinical significance due to their activating or drug-resistant effects, among which L858R is the most common oncogenic mutation occurring in EGFR and is frequently detected in a large subset of patients with NSCLC [31,32,33]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.